The iconic rise of Viagra has long been a benchmark of pharmaceutical success, but its legacy within the broader industry now raises questions about long-term returns . Copycat versions are undercutting https://bookmarkpressure.com/story21394599/the-blue-diamond-and-pharma-a-risky-venture